BEATRICE EDWARDS to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications BEATRICE EDWARDS has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
1.599
-
Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project. Drugs R D. 2017 Mar; 17(1):211-218.
Score: 0.558
-
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am. 2013 Feb 20; 95(4):297-307.
Score: 0.422
-
Reporting of serious adverse events during cancer clinical trials to the institutional review board: an evaluation by the research on adverse drug events and reports (RADAR) project. J Clin Pharmacol. 2013 Dec; 53(12):1334-40.
Score: 0.110
-
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol. 2014 Feb; 44(2):173-80.
Score: 0.110
-
Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project. Drug Saf. 2013 May; 36(5):335-47.
Score: 0.107
-
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project. J Oncol Pract. 2013 Mar; 9(2):101-6.
Score: 0.106
-
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. 2009 Jun 01; 15(11):3850-5.
Score: 0.081
-
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. 2008 Dec; 9(12):1166-72.
Score: 0.079
-
Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature. Expert Opin Drug Saf. 2014 Jan; 13(1):15-23.
Score: 0.027